Bsenexus Terminal Open in Bsenexus App →
BSE: 524715 SUNPHARMA NSE

SUN PHARMACEUTICAL IND L (524715) — Latest Corporate Announcements

₹1,759.8 ₹-21.20 (-1.19%)
Market Cap ₹4,22,234.97 Cr
P/E Ratio 34.92
52W Range ₹1583.7 – ₹2046.9

Corporate Actions & Regulatory Filings

Board Meeting Intimation for Consideration And Approval Of The Issuance Of Listed, Rated, Unsecured, Redeemable, Non-Convertible Debentures Announcement under Regulation 30 (LODR)-Press Release / Media Release Announcement under Regulation 30 (LODR)-Newspaper Publication Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Announcement under Regulation 30 (LODR)-Press Release / Media Release Announcement under Regulation 30 (LODR)-Newspaper Publication ESG Overview For FY 2025-26 Completion And Result Of Postal Ballot Dated 25 August 2026 Announcement under Regulation 30 (LODR)-Press Release / Media Release Receipt Of Approval Of The Shareholders For Reclassification Of Shareholder Category Closure of Trading Window Announcement under Regulation 30 (LODR)-Investor Presentation Intimation Under Regulation 30 Of SEBI LODR Incorporation Of A Subsidiary Company Announcement under Regulation 30 (LODR)-Credit Rating Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Announcement under Regulation 30 (LODR)-Press Release / Media Release Announcement under Regulation 30 (LODR)-Newspaper Publication Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Financial Results (Quarterly & Annual)

Quarter / Period Meeting / Outcome Date Status Filing Details
Quarter Ended 30-Jun-2026 (Q1 FY27) (STD & CONSOL) 31 Jul 2026 Declared Unaudited Standalone And Consolidated Financial Results For Q1 Of FY 2026-27
📄 View Quarter Ended 30-Jun-2026 (Q1 FY27) (STD & CONSOL) Results PDF ↗
Year Ended 31-Mar-2026 (Q4 FY26) 22 May 2026 Declared Dividend & Results
Quarter Ended 31-Dec-2025 (Q3 FY26) 31 Jan 2026 Declared Dividend & Results
Quarter Ended 30-Sep-2025 (Q2 FY26) 05 Nov 2025 Declared Results
Quarter Ended 30-Jun-2025 (Q1 FY26) 31 Jul 2025 Declared Results
Year Ended 31-Mar-2025 (Q4 FY25) 22 May 2025 Declared Dividend & Results
Quarter Ended 31-Dec-2024 (Q3 FY25) 31-Jan-2025 Declared To consider and approve the financial results for the period ended December 31, 2024 and Interim dividend for FY 2024-25
Quarter Ended 30-Sep-2024 (Q2 FY25) 28-Oct-2024 Declared To consider and approve the financial results for the period ended September 30, 2024
Quarter Ended 30-Jun-2024 (Q1 FY25) 01-Aug-2024 Declared To consider and approve Quarterly Financial Results for Q1 of FY 2024-25
Year Ended 31-Mar-2024 (Q4 FY24) 22-May-2024 Declared To consider and approve the audited financial results for the period ended March 31, 2024 and final dividend
Quarter Ended 31-Dec-2023 (Q3 FY24) 31-Jan-2024 Declared To consider and approve the financial results for the period ended December 31, 2023 and interim dividend
Quarter Ended 30-Sep-2023 (Q2 FY24) 01-Nov-2023 Declared To consider and approve the financial results for the period ended September 30, 2023

Track Related Peer Equities

RELIANCE Track Reliance Industries Ltd Filings → TCS Track Tata Consultancy Services Ltd Filings → HDFCBANK Track HDFC Bank Ltd Filings → INFY Track Infosys Ltd Filings →

Related Research Guides & Regulatory Playbooks

SEBI LODR Regulation 30 Material Disclosures, Timelines & Filing Rules → Results Calendar Guide Earnings Dates, Board Notices & LODR Reg 33 → Shareholding Patterns Promoter Staking, Pledging & FII/DII Reg 31 → Insider Trading & PIT Trading Window Closures & Promoter Filings →

Frequently Asked Questions about SUN PHARMACEUTICAL IND L BSE Disclosures

What is the latest BSE announcement by SUN PHARMACEUTICAL IND L?

The latest BSE disclosure by SUN PHARMACEUTICAL IND L (SUNPHARMA), filed on 2026-10-07T20:39:10, is: "Board Meeting Intimation for Consideration And Approval Of The Issuance Of Listed, Rated, Unsecured, Redeemable, Non-Convertible Debentures". Bsenexus tracks every official filing for SUN PHARMACEUTICAL IND L with AI-powered summaries on its announcements feed.

When is SUN PHARMACEUTICAL IND L's next board meeting?

No upcoming board meeting is currently tracked for SUN PHARMACEUTICAL IND L. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.

When does SUN PHARMACEUTICAL IND L declare quarterly results?

Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. SUN PHARMACEUTICAL IND L's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.

Track SUN PHARMACEUTICAL IND L Announcements on Bsenexus Live Terminal →